
Loading...

India’s drug regulatory body is planning several major changes to make its work easier and more efficient. The reforms are intended to ease the workload of the agency's small team, which is responsible for overseeing the country's massive drug industry.
About the Author

Mahek Sancheti, BAJMC graduate with a deep passion for writing. As a content writer, video content creator, creative content creator, and scriptwriter, I bring stories to life through words and visuals. I honed my skills by working with a prominent news agency, where I excelled in crafting compelling narratives and engaging content. Coming from a journalism and mass communication background I have skills to craft engaging narratives that captivate audiences. With a keen interest in writing and creativity, I aim to deliver impactful and meaningful content that resonates with diverse audiences.
2023-02-27 • 173923 views
CDSCO Issues Advisory against Misleading Promotion of GLP-1 Prescription Drugs
2026-03-13 • 0 views
2026-03-16 • 0 views